Table 4.

Change from baseline to EoT in MoCA subscale scores (SAF)

Change, mean (SD)	Placebo (n = 411)	Mirabegron Total (n = 425)
Attention Points	−0.0 (0.9)	−0.1 (0.9)
Language Points	0.0 (0.7)	0.0 (0.7)
Naming Points	−0.0 (0.4)	0.0 (0.4)
Visuospatial/Executive Points	0.0 (1.0)	−0.1 (1.2)
Abstraction Points	0.0 (0.5)	−0.0 (0.5)
Delayed Recall Points	0.2 (1.4)	0.2 (1.3)
Orientation Points	−0.0 (0.4)	−0.0 (0.4)

EoT end of treatment, MoCA Montreal Cognitive Assessment, SAF safety analysis set, SD standard deviation